On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions

Published:2019-09 Issue: Volume:100 Page:101703
ISSN:0933-3657
Container-title:Artificial Intelligence in Medicine
language:en
Short-container-title:Artificial Intelligence in Medicine

Author:

Puente Javier,Gascon Fernando,Ponte Borja,de la Fuente David

Funder

Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund

Publisher

Elsevier BV

Subject

Artificial Intelligence,Medicine (miscellaneous)

Reference75 articles.

1. Innovative strategies, statistical solutions and simulations for modern clinical trials;Chang,2019

2. The Clinical Innovation Network: a policy for promoting development of drugs and medical devices in Japan;Matsushita;Drug Discov Today,2019

3. Phase II and phase III failures: 2013–2015;Harrison;Nat Rev Drug Discov,2016

4. New clinical trial designs in the era of precision medicine: an overview of definitions, strengths, weaknesses, and current use in oncology;Janiaud;Cancer Treat Rev,2018

5. Innovation in oncology clinical trial design;Verweij;Cancer Treat. Rev.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Build a Risk Management Culture that Supports Diffusion of Innovation? A Systematic Review;The Effect of Information Technology on Business and Marketing Intelligence Systems;2023

2. The effect of the drug "Cobazin" on the productive indicators of bee colonies;EUREKA: Health Sciences;2021-03-31

3. A Model for the Strategic Management of Innovation and R&D Based on Real Options Valuation: Assessing the Options to Abandon and Expand Clinical Trials in Pharmaceutical Firms;Transactions on Computational Science and Computational Intelligence;2021

4. Integrating Sustainability in the Quality Assessment of EHEA Institutions: A Hybrid FDEMATEL-ANP-FIS Model;Sustainability;2020-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3